Document Detail


Patient autonomy and the regulation of direct-to-consumer advertising.
MedLine Citation:
PMID:  11813936     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The current direction of the US Food and Drug Administration (FDA) policy on direct-to-consumer advertising (DTCA) of pharmaceuticals is a subject of debate. The literature addresses the benefits and drawbacks of DTCA, but the foundations for such policies have not been investigated in detail. OBJECTIVE: This paper explores the most recent FDA guidance on broadcast DTCA based on a critical examination of the principle of autonomy. CONCLUSIONS: Autonomy is determined not by the ability to choose a therapy, but by the ability to actively participate in choices about health care. DTCA can be an effective tool to increase patient awareness of their therapeutic choices, encourage patients to seek more information, and help them draw closer to autonomous choices, but only if the presentations provide fair and balanced information on the benefits and risks of therapy.
Authors:
W M Zachry; D B Ginsburg
Related Documents :
19440396 - Emerging patient-driven health care models: an examination of health social networks, c...
17062596 - Rearranging the deck chairs.
18793286 - Issues in evaluating fish consumption rates for native american tribes.
11272346 - Baltimore's consumer ombudsman and assistance program: an emerging public health servic...
22236336 - Ethnic diversity outpatient clinic in paediatrics.
24622976 - Spousal social support and strain: impacts on health in older couples.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical therapeutics     Volume:  23     ISSN:  0149-2918     ISO Abbreviation:  Clin Ther     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2002-01-29     Completed Date:  2002-07-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7706726     Medline TA:  Clin Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2024-37; discussion 2022-3     Citation Subset:  E; IM    
Affiliation:
Department of Pharmacy Practice and Science, University of Arizona, Tucson 85721-0207, USA. zachry@pharmacy.arizona.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Advertising as Topic / legislation & jurisprudence*
Drug Industry*
Humans
Personal Autonomy*
Physician-Patient Relations
United States
United States Food and Drug Administration*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variability in the assessment of adverse events in a multicenter clinical trial.
Next Document:  Cost-Effectiveness of tolterodine for patients with urge incontinence who discontinue initial therap...